Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Breast Cancer Female 1Arthralgia 1

Interventions

Letrozole 4Anastrozole 4exemestane 2Testosterone 2Surveys and Questionnaires 2Fatty Acids, Omega-3 2Exercise 2Educational Status 2Aromatase Inhibitors 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1Yoga 1Walking 1Vitamin B 12 1Therapeutics 1Tamoxifen 1Glucosamine 1Glucaric Acid 1Fish Oils 1Docosahexaenoic Acids 1Diphosphonates 1Denosumab 1Curcumin 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1Calcium Citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthralgia × Cannabidiol × Breast × Clear all
NCT04754399 2025-05-09

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

University of Michigan Rogel Cancer Center

Phase 2 Completed
40 enrolled 10 charts
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡